IncFact
Company Profiles: Revenue, Growth, Competition

NOVABAY PHARMACEUTICALS Revenue, Growth & Competitor Profile

DBA (A DEVELOPMENT STAGE COMPANY)
Last updated:

Company Awards

 
Public Company
public company
Fast Growing
Fastest Growing
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Novabay Pharmaceuticals

Access the complete profile.

Novabay Pharmaceuticals Fast Facts

Revenue$10 - $100 million    See Exact Annual Revenue
Employees10 - 100Exact Company Size
Primary Industry325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes32541
325412 Pharmaceutical Preparation Manufacturing
Address2000 Powell Street, Suite 1150
Emeryville, CA 94608

novabaypharma.com
Note: Revenues for privately held companies are statistical evaluations.


Novabay Pharmaceuticals's annual revenues are $10-$50 million (see exact revenue data) and has 10-100 employees. It is classified as operating in the Medicinal & Botanical Manufacturing industry.


Novabay Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

Novabay Pharmaceuticals Annual Revenue and Growth Rate

Novabay Pharmaceuticals Revenue Est.
($ Million)
Growth Rate (%)# Employees
2023 Details in Premium Report
2022
2021
2020
2019


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Novabay Pharmaceuticals's revenues are gauged from an analysis of company filings.



Novabay Pharmaceuticals's Income Statement (based on Industry Averages)

$ Millions
(Industry Average)
Novabay Pharmaceuticals Revenue (Sales) Novabay Pharmaceuticals Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Trademark Applications

Trademark applications show the products and services that Novabay Pharmaceuticals is developing and marketing. Novabay Pharmaceuticals's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
COMFORT & JOY
Medicated personal care products, namely, lotions, creams, ointments, serums, oils, soap, cleansers, shower gel, shampoo, conditioner, beauty masks, scrubs, bathing treatments, balms and sunscreen
06/22/2022
AVENOVA
PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF INFECTIONS; CLEANSING SOLUTIONS FOR MEDICAL USE; DISINFECTANTS FOR MEDICAL INSTRUMENTS; MEDICAL CLEANSERS FOR SKIN AND WOUNDS; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF EYE DISEASES AND CONDITIONS; PHARMACEUTICAL PREPARATIONS FOR WOUNDS; PREPARATIONS FOR CLEANSING THE SKIN FOR MEDICAL USE; PRODUCTS AND PREPARATIONS FOR CLEANSING THE SKIN FOR MEDICAL USE
12/08/2014
NEUTROX
HYPOCHLOROUS ACID SOLD AS A COMPONENT INGREDIENT OF PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF INFECTIONS; HYPOCHLOROUS ACID SOLD AS A COMPONENT INGREDIENT OF CLEANSING SOLUTIONS FOR MEDICAL USE; HYPOCHLOROUS ACID SOLD AS A COMPONENT INGREDIENT OF DISINFECTANTS FOR MEDICAL INSTRUMENTS; HYPOCHLOROUS ACID SOLD AS A COMPONENT INGREDIENT OF MEDICAL CLEANSERS FOR SKIN AND WOUNDS; HYPOCHLOROUS ACID SOLD AS A COMPONENT INGREDIENT OF PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF EYE DISEASES AND CONDITIONS; HYPOCHLOROUS ACID SOLD AS A COMPONENT INGREDIENT OF PHARMACEUTICAL PREPARATIONS FOR WOUNDS; HYPOCHLOROUS ACID SOLD AS A COMPONENT INGREDIENT OF PREPARATIONS FOR CLEANSING THE SKIN FOR MEDICAL USE; HYPOCHLOROUS ACID SOLD AS A COMPONENT INGREDIENT OF PRODUCTS AND PREPARATIONS FOR CLEANSING THE SKIN FOR MEDICAL USE
10/16/2014

See all trademarks and details in the Full Report.


Recession Risk

Determine whether Novabay Pharmaceuticals grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Novabay Pharmaceuticals is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



U.S. Industry Overview & Market Statistics:
Medicinal & Botanical Manufacturing

Publisher: AnythingResearch

  • Market Size
  • Growth Rate
  • 5-Year Market Forecast
  • Average Company Size & Growth
  • Salary & Compensation Benchmarks



Market Share of Novabay Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Novabay Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
VITALABSMcdonough, GA100 
COUNTRY LANE SALESFairview, UT81 
VITA-PURERoselle, NJ44 
INPIVOTALindon, UT42 
NEW SPIRIT NATURALSSan Dimas, CA24 
MICROBE FORMULASMeridian, ID14 
EXEGI PHARMARockville, MD13 
MEDS & FOOD FOR KIDSSaint Louis, MO9 




Nearby Competitors

These companies are similar in business line and location to Novabay Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
AMYRISEmeryville, CA100 
SANTEN HOLDINGS USEmeryville, CA31 
SOUND AGRICULTUREEmeryville, CA19 
GRITSTONE BIOEmeryville, CA14 
DRIP DROP HYDRATIONEmeryville, CA4 
NOVABAY PHARMACEUTICALSEmeryville, CA1 




Future Competition: Novabay Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Novabay Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Novabay Pharmaceuticals Competitors